| Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials M Merabishvili, JP Pirnay, G Verbeken, N Chanishvili, M Tediashvili, ... PloS one 4 (3), e4944, 2009 | 617 | 2009 |
| Phage therapy—history from Twort and d'Herelle through Soviet experience to current approaches N Chanishvili Advances in virus research 83, 3-40, 2012 | 455 | 2012 |
| Importance of lactobacilli in food and feed biotechnology G Giraffa, N Chanishvili, Y Widyastuti Research in microbiology 161 (6), 480-487, 2010 | 447 | 2010 |
| The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? JP Pirnay, D De Vos, G Verbeken, M Merabishvili, N Chanishvili, ... Pharmaceutical research 28, 934-937, 2011 | 344 | 2011 |
| Quality and safety requirements for sustainable phage therapy products JP Pirnay, BG Blasdel, L Bretaudeau, A Buckling, N Chanishvili, JR Clark, ... Pharmaceutical research 32, 2173-2179, 2015 | 249 | 2015 |
| Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind … L Leitner, A Ujmajuridze, N Chanishvili, M Goderdzishvili, I Chkonia, ... The Lancet Infectious Diseases 21 (3), 427-436, 2021 | 247 | 2021 |
| Taxonomy of prokaryotic viruses: 2018-2019 update from the ICTV Bacterial and Archaeal Viruses Subcommittee EM Adriaenssens, MB Sullivan, P Knezevic, LJ van Zyl, BL Sarkar, ... Archives of virology 165 (5), 1253-1260, 2020 | 179 | 2020 |
| Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial L Leitner, W Sybesma, N Chanishvili, M Goderdzishvili, A Chkhotua, ... BMC urology 17, 1-6, 2017 | 169 | 2017 |
| Bacteriophage‐derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa T Glonti, N Chanishvili, PW Taylor Journal of applied microbiology 108 (2), 695-702, 2010 | 163 | 2010 |
| Adapted bacteriophages for treating urinary tract infections A Ujmajuridze, N Chanishvili, M Goderdzishvili, L Leitner, U Mehnert, ... Frontiers in microbiology 9, 1832, 2018 | 153 | 2018 |
| Expert opinion on three phage therapy related topics: bacterial phage resistance, phage training and prophages in bacterial production strains C Rohde, G Resch, JP Pirnay, BG Blasdel, L Debarbieux, D Gelman, ... Viruses 10 (4), 178, 2018 | 152 | 2018 |
| Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae A Eskenazi, C Lood, J Wubbolts, M Hites, N Balarjishvili, L Leshkasheli, ... Nature Communications 13 (1), 302, 2022 | 150 | 2022 |
| Phages and their application against drug‐resistant bacteria N Chanishvili, T Chanishvili, M Tediashvili, PA Barrow Journal of Chemical Technology & Biotechnology 76 (7), 689-699, 2001 | 149 | 2001 |
| Literature review of the practical application of bacteriophage research N Chanishvili Nova Science Publishers, Incorporated, 2012 | 143 | 2012 |
| Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization) M Merabishvili, C Vervaet, JP Pirnay, D De Vos, G Verbeken, J Mast, ... PloS one 8 (7), e68797, 2013 | 133 | 2013 |
| Bacteriophages as potential treatment for urinary tract infections W Sybesma, R Zbinden, N Chanishvili, M Kutateladze, A Chkhotua, ... Frontiers in microbiology 7, 465, 2016 | 121 | 2016 |
| Bacteriophages as therapeutic and prophylactic means: summary of the Soviet and post Soviet experiences N Chanishvili Current drug delivery 13 (3), 309-323, 2016 | 98 | 2016 |
| Strategy for Identification of Bacillus cereus and Bacillus thuringiensis Strains Closely Related to Bacillus anthracis D Daffonchio, N Raddadi, M Merabishvili, A Cherif, L Carmagnola, ... Applied and environmental microbiology 72 (2), 1295-1301, 2006 | 86 | 2006 |
| Phenotypic and genotypic variations within a single bacteriophage species PJ Ceyssens, T Glonti, M Kropinski, R Lavigne, N Chanishvili, L Kulakov, ... Virology journal 8, 1-5, 2011 | 85 | 2011 |
| Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104: H4 strain from the 2011 outbreak in Germany M Merabishvili, D De Vos, G Verbeken, AM Kropinski, D Vandenheuvel, ... PLoS One 7 (12), e52709, 2012 | 66 | 2012 |
